MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Amy DING Suneel GUPTA Liang, C. DONG Ann HSU |
| description | The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
La invención proporciona una formulación oral sólida de liberación controlada que comprende (a) un componente de liberación controlada que comprende un núcleo que comprende levodopa y/o un éster de levodopa o sus sales, en donde el núcleo está recubierto con una capa de un polímero muco-adhesivo y recubierto externamente con una capa de un polímero de recubrimiento entérico; y (b) un componente inhibidor de descarboxilasa. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2019013171A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2019013171A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2019013171A3</originalsourceid><addsrcrecordid>eNqNyr0KwjAUhuEuDqLew8HZYmOH4hiaL7SQ5Eh-ilspEifRQr1_XNxcnN7heddFtqnlUqoOoR9woJZd9GwMFHkYyADS7G0yMvbsArEmg4EVXyRJp47sCSHC_wilgECxgwfrbbG6T48l777dFHuN2HZlnl9jXubplp_5PdrrqRLnStSiEbL-a_oA56w1Lw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF</title><source>esp@cenet</source><creator>Amy DING ; Suneel GUPTA ; Liang, C. DONG ; Ann HSU</creator><creatorcontrib>Amy DING ; Suneel GUPTA ; Liang, C. DONG ; Ann HSU</creatorcontrib><description>The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
La invención proporciona una formulación oral sólida de liberación controlada que comprende (a) un componente de liberación controlada que comprende un núcleo que comprende levodopa y/o un éster de levodopa o sus sales, en donde el núcleo está recubierto con una capa de un polímero muco-adhesivo y recubierto externamente con una capa de un polímero de recubrimiento entérico; y (b) un componente inhibidor de descarboxilasa.</description><language>eng ; spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191218&DB=EPODOC&CC=MX&NR=2019013171A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191218&DB=EPODOC&CC=MX&NR=2019013171A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Amy DING</creatorcontrib><creatorcontrib>Suneel GUPTA</creatorcontrib><creatorcontrib>Liang, C. DONG</creatorcontrib><creatorcontrib>Ann HSU</creatorcontrib><title>MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF</title><description>The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
La invención proporciona una formulación oral sólida de liberación controlada que comprende (a) un componente de liberación controlada que comprende un núcleo que comprende levodopa y/o un éster de levodopa o sus sales, en donde el núcleo está recubierto con una capa de un polímero muco-adhesivo y recubierto externamente con una capa de un polímero de recubrimiento entérico; y (b) un componente inhibidor de descarboxilasa.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAUhuEuDqLew8HZYmOH4hiaL7SQ5Eh-ilspEifRQr1_XNxcnN7heddFtqnlUqoOoR9woJZd9GwMFHkYyADS7G0yMvbsArEmg4EVXyRJp47sCSHC_wilgECxgwfrbbG6T48l777dFHuN2HZlnl9jXubplp_5PdrrqRLnStSiEbL-a_oA56w1Lw</recordid><startdate>20191218</startdate><enddate>20191218</enddate><creator>Amy DING</creator><creator>Suneel GUPTA</creator><creator>Liang, C. DONG</creator><creator>Ann HSU</creator><scope>EVB</scope></search><sort><creationdate>20191218</creationdate><title>MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF</title><author>Amy DING ; Suneel GUPTA ; Liang, C. DONG ; Ann HSU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2019013171A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Amy DING</creatorcontrib><creatorcontrib>Suneel GUPTA</creatorcontrib><creatorcontrib>Liang, C. DONG</creatorcontrib><creatorcontrib>Ann HSU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Amy DING</au><au>Suneel GUPTA</au><au>Liang, C. DONG</au><au>Ann HSU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF</title><date>2019-12-18</date><risdate>2019</risdate><abstract>The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
La invención proporciona una formulación oral sólida de liberación controlada que comprende (a) un componente de liberación controlada que comprende un núcleo que comprende levodopa y/o un éster de levodopa o sus sales, en donde el núcleo está recubierto con una capa de un polímero muco-adhesivo y recubierto externamente con una capa de un polímero de recubrimiento entérico; y (b) un componente inhibidor de descarboxilasa.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2019013171A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T12%3A08%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Amy%20DING&rft.date=2019-12-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2019013171A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |